Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Warfarin Management in Patients with Atrial Fibrillation — Current Practice Study [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2012 Mar. (CADTH Optimal Use Report, No. 1.2D.)
Warfarin Management in Patients with Atrial Fibrillation — Current Practice Study [Internet].
Show detailsThe objective of this current practice study was to explore the views and experiences of health care professionals and patients with atrial fibrillation regarding the use of warfarin and management of warfarin therapy for the prevention of thromboembolic events.
- OBJECTIVE - Warfarin Management in Patients with Atrial Fibrillation — Current P...OBJECTIVE - Warfarin Management in Patients with Atrial Fibrillation — Current Practice Study
- SP140 nuclear body protein isoform 1 [Homo sapiens]SP140 nuclear body protein isoform 1 [Homo sapiens]gi|52487219|ref|NP_009168.3|Protein
- cytochrome b, partial (mitochondrion) [Stenocephalemys albipes]cytochrome b, partial (mitochondrion) [Stenocephalemys albipes]gi|1549117503|gb|AZU96872.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...